As shown in Figure 7a and b, compared with the sh-NC group, the tumor size and tumor weight in the sh-NC + Tax group treated with Tax were downregulated, which suggested that Tax treatment could control GC tumor development in vivo. The gene discussed is CNTN2; the disease is gastric cancer.